FOXO1 and diabetic cardiomyopathy: Thus, we hypothesized that Ang IV protects against diabetic cardiomyopathy via stimulation of AT4R and inhibition of FoxO1-enhanced autophagy, and a series of in vivo and in vitro experiments were designed and performed in this study to test this hypothesis.